- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT03178513
Post-Acute Physician Home Visit Program
Post-Acute Physician Home Visits: A Randomized Controlled Trial
Studie Overzicht
Toestand
Interventie / Behandeling
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Massachusetts
-
Boston, Massachusetts, Verenigde Staten, 02115
- Brigham and Women's Hospital
-
Boston, Massachusetts, Verenigde Staten, 02130
- Brigham and Women's Faulkner Hospital
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Resides within either a 5-mile or 20-minute driving radius of Brigham and Women's Hospital (BWH) or Brigham and Women's Faulkner Hospital (BWFH) emergency room
- Has capacity to consent to study
- >=18 years old
Exclusion Criteria:
- Undomiciled
- In police custody
- Domestic violence screen positive
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ondersteunende zorg
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
---|---|
Experimenteel: Home visit
A participant in this arm will receive a home visit after discharge from the hospital.
|
The visit will be entirely patient tailored, last approximately one hour, and at a minimum will entail:
|
Geen tussenkomst: Usual Care
A participant in this arm will not receive a home visit after discharge from the hospital.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
New or worsening symptoms
Tijdsspanne: 30 days after discharge from hospital
|
"Since you got home from the hospital, have you had any symptoms at all?" If no, stop. If yes, continue. "I'm going to read off a list of symptoms, and I want you to tell me if that symptom is new or has gotten worse since you left the hospital. Please don't include symptoms that have stayed the same since you were in the hospital." For each affirmative, double check if the symptom is new or has gotten worse since getting out of the hospital. Only if new or worse, mark yes. |
30 days after discharge from hospital
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
3-item Zorgtransitiemaatregel, score
Tijdsspanne: 30 dagen na ontslag
|
30 dagen na ontslag
|
|
Total cost, 30-days post discharge
Tijdsspanne: Day of discharge to 30 days later
|
Day of discharge to 30 days later
|
|
Total reimbursement, 30-days post discharge
Tijdsspanne: Day of discharge to 30 days later
|
Day of discharge to 30 days later
|
|
Primary care provider follow-up within 14 days, y/n
Tijdsspanne: Day of discharge to 14 days later
|
Day of discharge to 14 days later
|
|
Ability to carry out the discharge plan, score
Tijdsspanne: 30 days after discharge
|
I would like to ask you about some more problems that you might have faced after you left the hospital one month ago.
I will read some statements and ask if you agree or disagree.
|
30 days after discharge
|
Change in medication list due to home visit, y/n
Tijdsspanne: Day of home visit
|
Physician-initiated medication change during home visit
|
Day of home visit
|
Receipt of prescribed medicines following discharge, y/n
Tijdsspanne: 30 days after discharge
|
Pharmacy confirmation
|
30 days after discharge
|
Unplanned 30-day readmission(s) after index hospitalization, y/n
Tijdsspanne: 30 days after discharge
|
30 days after discharge
|
|
Unplanned 30-day readmission(s) after index hospitalization, #
Tijdsspanne: 30 days after discharge
|
30 days after discharge
|
Andere uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Global satisfaction with care, score
Tijdsspanne: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Days at home since discharge, #
Tijdsspanne: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
All-cause 30-day readmission(s) after index hospitalization, y/n
Tijdsspanne: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
All-cause 30-day readmission(s) after index hospitalization, #
Tijdsspanne: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Emergency Department (ED) observation stay(s) after index hospitalization, y/n
Tijdsspanne: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Emergency Department (ED) observation stay(s) after index hospitalization, #
Tijdsspanne: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Emergency Department (ED) visit(s) after index hospitalization, #
Tijdsspanne: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Emergency Department (ED) visit(s) after index hospitalization, y/n
Tijdsspanne: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Imaging, #
Tijdsspanne: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Imaging, y/n
Tijdsspanne: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Lab orders, #
Tijdsspanne: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Lab orders, y/n
Tijdsspanne: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Physician visits, y/n
Tijdsspanne: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Physician visits, #
Tijdsspanne: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Home health utilization, days
Tijdsspanne: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Home health utilization, y/n
Tijdsspanne: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
All cause 30-day mortality, y/n
Tijdsspanne: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Unplanned 30-day mortality, y/n
Tijdsspanne: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Change in medication list due to error at discharge, y/n
Tijdsspanne: Visit date
|
Exploratory
|
Visit date
|
Pneumococcal vaccination if appropriate, y/n
Tijdsspanne: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Influenza vaccination if appropriate, y/n
Tijdsspanne: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Smoking cessation counseling if appropriate, y/n
Tijdsspanne: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Evaluation of ejection fraction as assessed by echocardiogram or other appropriate study, scheduled or completed, if not done within 1 year; y/n
Tijdsspanne: 30 days after discharge
|
Heart failure patients only; Exploratory; appropriate studies include cardiac magnetic resonance imaging, radionuclide ventriculography, single photon emission computed tomography myocardial perfusion imaging, or left ventriculography
|
30 days after discharge
|
Angiotensin converting enzyme inhibitor or angiotensin receptor blocker for heart failure with reduced ejection fraction (ejection fraction < 40%), y/n
Tijdsspanne: 30 days after discharge
|
Heart failure patients only; Exploratory
|
30 days after discharge
|
Beta blocker for heart failure with reduced ejection fraction (ejection fraction < 40%), y/n
Tijdsspanne: 30 days after discharge
|
Heart failure patients only; Exploratory
|
30 days after discharge
|
Aldosterone antagonist for heart failure with reduced ejection fraction (ejection fraction < 40%), y/n
Tijdsspanne: 30 days after discharge
|
Heart failure patients only; Exploratory
|
30 days after discharge
|
Lipid lowering for coronary artery disease, peripheral vascular disease, cerebrovascular accident, or diabetes, y/n
Tijdsspanne: 30 days after discharge
|
Heart failure patients only; Exploratory
|
30 days after discharge
|
Smoking status post-discharge
Tijdsspanne: 30 days after discharge
|
Heart failure patients only; Exploratory
|
30 days after discharge
|
Use of inappropriate medications in the elderly, y/n
Tijdsspanne: 30 days after discharge
|
Exploratory; using Screening Tool of Older Persons' potentially inappropriate Prescriptions (STOPP) and Beers criteria
|
30 days after discharge
|
Time between discharge and visit, days
Tijdsspanne: Date of home visit
|
Exploratory
|
Date of home visit
|
Duration of physician visit, minutes
Tijdsspanne: Date of home visit
|
Exploratory
|
Date of home visit
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Jeffrey Schnipper, MD MPH, Brigham and Women's Hospital
Publicaties en nuttige links
Algemene publicaties
- Epstein K, Juarez E, Loya K, Gorman MJ, Singer A. Frequency of new or worsening symptoms in the posthospitalization period. J Hosp Med. 2007 Mar;2(2):58-68. doi: 10.1002/jhm.170.
- Boling PA. Care transitions and home health care. Clin Geriatr Med. 2009 Feb;25(1):135-48, viii. doi: 10.1016/j.cger.2008.11.005.
- Meyer GS, Gibbons RV. House calls to the elderly--a vanishing practice among physicians. N Engl J Med. 1997 Dec 18;337(25):1815-20. doi: 10.1056/NEJM199712183372507.
- Wong FK, Chow SK, Chan TM, Tam SK. Comparison of effects between home visits with telephone calls and telephone calls only for transitional discharge support: a randomised controlled trial. Age Ageing. 2014 Jan;43(1):91-7. doi: 10.1093/ageing/aft123. Epub 2013 Aug 26.
- Branowicki PM, Vessey JA, Graham DA, McCabe MA, Clapp AL, Blaine K, O'Neill MR, Gouthro JA, Snydeman CK, Kline NE, Chiang VW, Cannon C, Berry JG. Meta-Analysis of Clinical Trials That Evaluate the Effectiveness of Hospital-Initiated Postdischarge Interventions on Hospital Readmission. J Healthc Qual. 2017 Nov/Dec;39(6):354-366. doi: 10.1097/JHQ.0000000000000057.
- Wolff JL, Meadow A, Boyd CM, Weiss CO, Leff B. Physician evaluation and management of Medicare home health patients. Med Care. 2009 Nov;47(11):1147-55. doi: 10.1097/MLR.0b013e3181b58e30.
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Andere studie-ID-nummers
- P000719
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Home visit
-
National University, SingaporeNational University Hospital, SingaporeVoltooid
-
Kasr El Aini HospitalOnbekendUrologische chirurgische ingrepenEgypte